UnitedHealth Group reported first-quarter earnings that exceeded Wall Street expectations for both revenue and earnings per share, signaling effective management of high medical costs and operational streamlining [1]. The company posted adjusted earnings per share of $7.23, surpassing the analyst consensus of $6.57, and revenue of $111.72 billion, above the expected $109.57 billion [1]. Net income for the quarter was $6.28 billion, or $6.90 per share, compared to $6.29 billion, or $6.85 per share, in the same period last year [1]. Excluding items such as business divestitures and restructuring, adjusted earnings per share reached $7.23 [1].
UnitedHealth's medical benefit ratio, a key metric measuring total medical expenses paid relative to premiums collected, came in at 83.9% for the first quarter, an improvement from 84.8% in the prior year and better than the analyst expectation of 85.5% [1]. This lower ratio indicates increased profitability, as the company collected more in premiums than it paid out in benefits [1]. Both UnitedHealthcare and Optum, UnitedHealth's insurer and health-care unit respectively, topped analysts' sales estimates for the quarter [1].
The company maintained its full-year revenue guidance of greater than $439 billion, which it had previously set in January, and raised its 2026 adjusted earnings outlook to more than $18.25 per share, up from the prior forecast of more than $17.75 per share [1]. UnitedHealth is implementing a turnaround plan led by a new leadership team, which includes shrinking membership, selling the UK business of its Optum unit, investing heavily in artificial intelligence, streamlining access to care, and increasing transparency to restore profitability and reputation after recent challenges [1].
UnitedHealth's improved management of medical costs comes amid industry-wide pressures, particularly for insurers running Medicare plans, due to an influx of patients seeking delayed care and high-cost specialty drugs [1]. The company's strong performance and raised outlook suggest confidence in its ongoing turnaround strategy and cost management initiatives [1].
CONCLUSION
UnitedHealth Group's first-quarter results exceeded expectations, driven by improved cost management and operational efficiency. The company raised its 2026 profit outlook and maintained robust revenue guidance, signaling positive momentum and market confidence. These developments are likely to have a significant impact on investor sentiment and the broader insurance sector.